A Safety Evaluation of ECG Intervals and Blood Pressure in Normal Healthy Volunteers After Use of Nebivolol, Atenolol, Moxifloxacin, or Placebo

This study has been completed.

Sponsor:

Information provided by:

Mylan Bertek Pharmaceuticals

ClinicalTrials.gov Identifier:

NCT00158093

First received: September 7, 2005

Last updated: NA

Last verified: September 2005

History: No changes posted

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	July 2003
Estimated Primary Completion Date:	No date given